Skip to main content
. 2003 Aug 26;89(5):795–802. doi: 10.1038/sj.bjc.6601217

Figure 2.

Figure 2

(A) Overall (solid line) and event-free (dotted line) survival for 33 patients with locally advanced NSCLC in the phase I portion of the study. (B) Overall (solid line) and event-free (dotted line) survival for 42 patients with locally advanced NSCLC in the phase II portion of the study. Censored cases are denoted by tics.